1. Home
  2. TCI vs CDTX Comparison

TCI vs CDTX Comparison

Compare TCI & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • CDTX
  • Stock Information
  • Founded
  • TCI 1983
  • CDTX 2012
  • Country
  • TCI United States
  • CDTX United States
  • Employees
  • TCI N/A
  • CDTX N/A
  • Industry
  • TCI Real Estate
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TCI Finance
  • CDTX Health Care
  • Exchange
  • TCI Nasdaq
  • CDTX Nasdaq
  • Market Cap
  • TCI 240.5M
  • CDTX 242.5M
  • IPO Year
  • TCI N/A
  • CDTX 2015
  • Fundamental
  • Price
  • TCI $29.51
  • CDTX $20.53
  • Analyst Decision
  • TCI
  • CDTX Strong Buy
  • Analyst Count
  • TCI 0
  • CDTX 6
  • Target Price
  • TCI N/A
  • CDTX $32.20
  • AVG Volume (30 Days)
  • TCI 4.5K
  • CDTX 86.5K
  • Earning Date
  • TCI 11-07-2024
  • CDTX 11-07-2024
  • Dividend Yield
  • TCI N/A
  • CDTX N/A
  • EPS Growth
  • TCI N/A
  • CDTX N/A
  • EPS
  • TCI 0.37
  • CDTX N/A
  • Revenue
  • TCI $49,821,000.00
  • CDTX $44,653,000.00
  • Revenue This Year
  • TCI N/A
  • CDTX N/A
  • Revenue Next Year
  • TCI N/A
  • CDTX N/A
  • P/E Ratio
  • TCI $80.90
  • CDTX N/A
  • Revenue Growth
  • TCI 4.46
  • CDTX 44.48
  • 52 Week Low
  • TCI $26.29
  • CDTX $10.00
  • 52 Week High
  • TCI $43.40
  • CDTX $24.99
  • Technical
  • Relative Strength Index (RSI)
  • TCI 58.03
  • CDTX 55.06
  • Support Level
  • TCI $27.82
  • CDTX $21.15
  • Resistance Level
  • TCI $30.95
  • CDTX $24.99
  • Average True Range (ATR)
  • TCI 0.94
  • CDTX 2.10
  • MACD
  • TCI 0.04
  • CDTX -0.15
  • Stochastic Oscillator
  • TCI 57.43
  • CDTX 41.16

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Share on Social Networks: